Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCA vs Silver Nitrate for Childhood Epistaxis
NCT06836791Completed
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of trichloroacetic acid in epistaxis (2 arms). Primary endpoint: rebleeding from the nose at 12 weeks. Started Mar 2023; status: completed.
02
Drugs
trichloroacetic acid
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT06836791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836791.